Risk factors for drug diversion in a pain clinic patient population

Mary Jean Walker, DNP; Lynn R. Webster, MD

doi:10.5055/jom.2012.0135

Authors

Mary Jean Walker, DNP
Lynn R. Webster, MD

DOI:

https://doi.org/10.5055/jom.2012.0135

Abstract

Background: Prescription drug abuse and drug diversion have soared at the same time prescribing practices have increased, prompting the pain medicine community to seek more accurate knowledge of the sources of prescription drugs used nonmedically.
Objective: To determine the extent of drug diversion and its risk factors in patients treated in a pain clinic. Methods: An anonymous patient survey was developed based on factors examined for their association with diversion identified from a literature search. Patients were asked to participate as they arrived for appointments at six chronic pain management clinics. Questions ascertained whether patients had experienced drug loss, theft, or diversion and, if so, the number of episodes. Data were analyzed to determine associations between identified risk factors and the following four identified ways of diverting prescription medications: stolen medications, lost medications, sharing of medications, and selling of medications. Data were also analyzed to determine the extent of drug diversion within the studied population.
Results: Respondents had experienced a 45 percent incidence of some form of drug diversion on at least one occasion. The most common type of drug diversion was loss due to theft, reported by 30 percent of the respondents. Findings suggest family history of drug abuse and a history of criminal behavior can increase likelihood of drug diversion. Conclusions: Drug diversion in a pain clinic population was common in this brief survey. Such diversion may contribute to the problems of nonmedical use of prescription drugs.
Keywords: drug diversion, pain clinic, prescription, patient
DOI:10.5055/jom.2012.0135

References

Substance Abuse and Mental Health Services Administration S:

National Estimates of Drug related Emergency Department Visits:

Office of Applied Studies, Substance Abuse and Mental Health

Services Administration, 2008. Available at www.samhsa.gov/data.

Accessed May 22, 2011.

Substance Abuse and Mental Health Services Administration

S: Results from the 2009 National Survey on Drug Use and

Health: Department of Health and Human Services, 2010.

Available at www.samhsa.gov/data. Accessed May 22, 2011.

Substance Abuse and Mental Health Services Administration

S: Prevalence and Recent Trends in Misuse of Prescription

Drugs: Office of Applied Studies 2008, updated June 3, 2008.

Available at www.samhsa.gov/data. Accessed June 25, 2011.

Bell J: The global diversion of pharmaceutical drugs.

Addiction. 2010; 105(9): 1531-1537.

McCabe SE: Correlates of nonmedical use of prescription

benzodiazepine anxiolytics: Results from a national survey of

U.S. college students. Drug Alcohol Depend. 2005; 79(1): 53-62.

Paulozzi LJ: Opioid analgesic involvement in drug abuse

deaths in American metropolitan areas. Am J Public Health.

; 96(10): 1755-1757.

National Drug Intelligence Centre N: National Prescription

Drug Threat Assessment. 2009. Available at www.justice.gov/

archive/ndic. Accessed May 29, 2011.

Fischer B, Bibby M, Bouchard M: The global diversion of

pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: A review of

sourcing routes and control measures Benedikt Fischer et al.

Diversion of psychotropic prescription drugs. Addiction. 2010;

(12): 2062-2070.

Inciardi JA, Surratt HL, Cicero TJ, et al.: Prescription drugs

purchased through the internet: Who are the end users? Drug

Alcohol Depend. 2010; 110(1-2): 21-29.

Rosenblum A, Parrino M, Schnoll SH, et al.: Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007; 90(1): 64-71.

National Survey on American Attitudes on Substance Abuse:

XV: Teens and Parents. New York, NY: The National Center on

Addiction and Substance Abuse at Columbia University, 2010.

Available at www.casacolumbia.org/upload/2010/20100819t

eensurvey.pdf. Accessed August 19, 2010.

McCabe SE, Boyd CJ: Sources of prescription drugs for illicit

use. Addict Behav. 2005; 30(7): 1342-1350.

Inciardi JA, Surratt HL, Kurtz SP, et al.: The diversion of prescription drugs by health care workers in Cincinnati, Ohio.

Subst Use Misuse. 2006; 41(2): 255-264.

Inciardi JA, Surratt HL, Cicero TJ, et al.: Prescription opioid

abuse and diversion in an urban community: The results of an

ultrarapid assessment. Pain Med. 2009; 10(3): 537-548.

Inciardi J, Surratt H, Cicero T, et al.: The “black box” of prescription drug diversion. J Addict Dis. 2009; 28(4): 332-347.

McCabe SE, Boyd CJ, Teter CJ: Medical use, illicit use, and

diversion of abusable prescription drugs. J Am Coll Health.

; 54(5): 269-278.

Butler SF, Budman SH, Fernandez KC, et al.: Development

and validation of the current opioid misuse measure. Pain.

; 130(1-2): 144-156.

Census US. Washington, DC: US Census Bureau, 2010.

Available at http://2010.census.gov/2010census/data. Accessed

June 17, 2011.

Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for

the use of chronic opioid therapy in chronic noncancer pain.

J Pain. 2009; 10(2): 113-30.e22.

Hall AJ, Logan JE, Toblin RL, et al.: Patterns of abuse among

unintentional pharmaceutical overdose fatalities. JAMA. 2008;

(22): 2613-2620.

Garnier LM, Arria AM, Caldeira KM, et al.: Sharing and selling of prescription medications in a college student sample.

J Clin Psychiatry. 2010; 71(3): 262-269.

McCabe SE, Cranford JA, Boyd CJ, et al.: Motives, diversion

and routes of administration associated with nonmedical use of

prescription opioids. Addict Behav. 2007; 32(3): 562-575.

Kelly BC, Parsons JT: Prescription drug misuse among club

drug-using young adults. Am J Drug Alcohol Abuse. 2007; 33(6):

-884.

Journal of Opioid Management 8:6 November/December 2012 361

Mary Jean Walker, DNP, College of Nursing, University of

Utah, Salt Lake City, Utah.

Lynn R. Webster, MD, Medical Director, Lifetree Clinical

Research, Salt Lake City, Utah.

Manchikanti L, Singh A: Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician.

; 11(2 Suppl): S63-S88.

Ives TJ, Chelminski PR, Hammett-Stabler CA, et al.:

Predictors of opioid misuse in patients with chronic pain: A

prospective cohort study. BMC Health Serv Res. 2006; 6: 46.

Spiller H, Lorenz DJ, Bailey EJ, et al.: Epidemiological trends

in abuse and misuse of prescription opioids. J Addict Dis. 2009;

(2): 130-136.

Office of National Drug Control Policy: Arrestee Drug Abuse

Monitoring Program 2009 annual report. Washington, DC:

Executive Office of the President, 2010. Available at

www.whitehouse.gov/site/default/files/ondcp/policy-andresearch/adam2009.pdf. Accessed August 14, 2011.

McCabe SE, Cranford JA, Boyd CJ: The relationship between

past-year drinking behaviors and nonmedical use of prescription drugs: Prevalence of co-occurrence in a national sample.

Drug Alcohol Depend. 2006; 84(3): 281-288.

Cicero TJ, Surratt H, Inciardi JA, et al.: Relationship between

therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007; 16(8): 827-840.

Anderson IB, Kim-Katz SY, Dyer JE, et al.: Area-level socioeconomic status in relation to outcomes in gamma-hydroxybutyrate intoxication. Clin Toxicol (Phila). 2009; 47(1): 48-57.

Havens JR, Talbert JC, Walker R, et al.: Trends in controlledrelease oxycodone (OxyContin) prescribing among Medicaid

recipients in Kentucky, 1998-2002. J Rural Health. 2006; 22(3):

-278.

Office of National Drug Control Policy: Prescription Drugs:

Executive Office of the President of the United States 2010.

Availablel at www.whitehouse.gov/ondcp/prescription-drugabuse. Accessed July 26, 2011.

Felson M, Boba R: Crime and Everyday Life. 4th ed.

Thousand Oaks, CA: Sage Publications, Inc., 2010.

Cicero TJ, Inciardi JA, Munoz A: Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002-2004.

J Pain. 2005; 6(10): 662-672.

Cicero TJ, Inciardi JA, Surratt H: Trends in the use and abuse

of branded and generic extended release oxycodone and fentanyl products in the United States. Drug Alcohol Depend. 2007;

(2-3): 115-120.

Inciardi JA, Surratt HL, Lugo Y, et al.: The diversion of prescription opioid analgesics. Law Enforc Exec Forum. 2007; 7(7):

-141.

Webster LR, Dove B: Avoiding opioid abuse while managing pain: A guide for practitioners. North Branch, MN: Sunrise

River Press, 2007.

Webster LR, Webster RM: Predicting aberrant behaviors in

opioid-treated patients: Preliminary validation of the Opioid

Risk Tool. Pain Med. 2005; 6(6): 432-442.

Cohen L, Felson M: Social change and crime rate trends: A

routine activity approach. Am Sociol Rev. 1979; 44(4): 588-608.

Inciardi JA, Surratt HL, Kurtz SP, et al.: Mechanisms of prescription drug diversion among drug-involved club- and streetbased populations. Pain Med. 2007; 8(2): 171-183.